Here's a podcast interview of Dr. Sam Gambhir briefing on impact of Molecular Imaging to the current medicine and healthcare of future. The interview was conducted by Lumera, a polymer nanotechnology corporation.
The key points Dr. Gambhir emphasized was the current knowledge of molecular interactions occuring in the cellular machinery is still insufficient for effective practice of medicine. The aim of MI research should focus to decipher such cellular interactions in their native state. In general the master controller of cellular processes is constituted by DNA or genetic makeup of the cell. Rapid advances in human genome sequencing and other imaging or biomarker diagnostic technologies could facilitate therapeutic interventions at earlier time points and both diagnostic tests and therapy options be customized to the individual patient.
The key points Dr. Gambhir emphasized was the current knowledge of molecular interactions occuring in the cellular machinery is still insufficient for effective practice of medicine. The aim of MI research should focus to decipher such cellular interactions in their native state. In general the master controller of cellular processes is constituted by DNA or genetic makeup of the cell. Rapid advances in human genome sequencing and other imaging or biomarker diagnostic technologies could facilitate therapeutic interventions at earlier time points and both diagnostic tests and therapy options be customized to the individual patient.
No comments:
Post a Comment